Clinical Trial Update: Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing satisfaction with orodispersible memantine versus conventional memantine in moderate to severe Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)
• Orodispersible Memantine (memantine)

Snippet

Sponsor: Carnot Laboratories | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED